NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has added John Mack to its Board of Directors, effective from July 29, 2024. Mack brings over 30 years of experience in medical devices, healthcare technology, and finance to the company.
Mack’s most recent role was as President of Cardiac Surgery at Medtronic plc. Under his leadership, the division secured market leadership. He also served as Vice President & General Manager of Extracorporeal Therapies and Vice President of Business Development, Strategy & Portfolio Management at Medtronic. There, he led business development for the coronary and structural heart business, a $3.2 billion global enterprise with over 12,000 employees.
“John is an esteemed member of the medical device community, and we are confident his extensive operational and strategic experience and proven leadership will be tremendous assets to the Orchestra BioMed Board,” said David Hochman, Chairman and CEO of Orchestra BioMed. “John’s outstanding track record includes helping guide Medtronic to market leadership in structural cardiology and strengthening their market leading position in cardiac surgery. He has a deep understanding of critical cardiovascular therapy markets and the role that high-impact, novel therapeutic devices can play in growing and transforming these markets. We expect his strong, industry-wide relationships to help us identify avenues for growth. We look forward to achieving new milestones together and realizing key opportunities to leverage our partnership-enabled business model.”
Mack expressed his enthusiasm for the new role: “I am honored to join Orchestra BioMed’s Board of Directors and enthusiastically support its mission to accelerate medical innovations and deliver life-changing therapies to patients. Having spent many years in the field, I have seen firsthand the transformative impact that innovation and the right strategic business relationships can have on patient care. The Company has real potential to make a significant contribution to the medical device landscape with its promising pipeline and partnership-enabled business model. I look forward to working with this dynamic organization and its team of visionaries.”
Besides his new role at Orchestra BioMed, Mack is a board member at the Minneapolis Heart Institute Foundation, a leading nonprofit cardiovascular research and education institution. He has also served on the boards of MC3 Cardiopulmonary and the Twin Cities American Heart Association. His leadership has garnered several accolades, including the Wallin Leadership Award and the Medtronic Star of Excellence Award.
Orchestra BioMed sees Mack’s appointment as a strategic move to bolster its mission of advancing medical innovations and improving patient care.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.